2243 related articles for article (PubMed ID: 24524923)
1. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
Karussis D
J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic inflammatory-demyelinating diseases of the central nervous system.
Cañellas AR; Gols AR; Izquierdo JR; Subirana MT; Gairin XM
Neuroradiology; 2007 May; 49(5):393-409. PubMed ID: 17333161
[TBL] [Abstract][Full Text] [Related]
3. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.
Kantarci OH; Lebrun C; Siva A; Keegan MB; Azevedo CJ; Inglese M; Tintoré M; Newton BD; Durand-Dubief F; Amato MP; De Stefano N; Sormani MP; Pelletier D; Okuda DT
Ann Neurol; 2016 Feb; 79(2):288-94. PubMed ID: 26599831
[TBL] [Abstract][Full Text] [Related]
4. Variants of multiple sclerosis.
Simon JH; Kleinschmidt-DeMasters BK
Neuroimaging Clin N Am; 2008 Nov; 18(4):703-16, xi. PubMed ID: 19068410
[TBL] [Abstract][Full Text] [Related]
5. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
[TBL] [Abstract][Full Text] [Related]
6. Atypical inflammatory demyelinating lesions and atypical multiple sclerosis.
Ayrignac X; Carra-Dallière C; Labauge P
Rev Neurol (Paris); 2018 Jun; 174(6):408-418. PubMed ID: 29673573
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
[TBL] [Abstract][Full Text] [Related]
8. Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions.
Dale RC; Pillai SC
Dev Med Child Neurol; 2007 Dec; 49(12):887-93. PubMed ID: 18039234
[TBL] [Abstract][Full Text] [Related]
9. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis.
Dale RC; Brilot F; Banwell B
Curr Opin Neurol; 2009 Jun; 22(3):233-40. PubMed ID: 19434783
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
Teunissen CE; Sombekke M; van Winsen L; Killestein J; Barkhof F; Polman CH; Dijkstra CD; Blankenstein MA; Pratico D
Mult Scler; 2012 Aug; 18(8):1092-8. PubMed ID: 22695538
[TBL] [Abstract][Full Text] [Related]
11. The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis.
Idiman E; Ozakbaş S
Expert Rev Neurother; 2011 Mar; 11(3):451-62. PubMed ID: 21375450
[TBL] [Abstract][Full Text] [Related]
12. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
Wegner C
Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
[TBL] [Abstract][Full Text] [Related]
13. [Clinical subtypes of multiple sclerosis and the immuno-pathogeneses].
Fujihara K
Nihon Rinsho; 2003 Aug; 61(8):1293-9. PubMed ID: 12962014
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
Gajofatto A; Bongianni M; Zanusso G; Bianchi MR; Turatti M; Benedetti MD; Monaco S
Acta Neurol Scand; 2013 Nov; 128(5):336-44. PubMed ID: 23550839
[TBL] [Abstract][Full Text] [Related]
15. The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
Papais-Alvarenga RM; Vasconcelos CC; Alves-Leon SV; Batista E; Santos CM; Camargo SM; Godoy M; Lacativa MC; Lorenti M; Damasceno B; Damasceno A; Brum D; Barreira AA; Guimarães Rocha MS; Alvarenga H; Tilbery CP
Mult Scler; 2014 Mar; 20(3):374-81. PubMed ID: 23970504
[TBL] [Abstract][Full Text] [Related]
16. Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
Frederick MC; Cameron MH
Curr Neurol Neurosci Rep; 2016 Mar; 16(3):26. PubMed ID: 26847090
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic criteria of borderline forms of multiple sclerosis].
Dupel-Pottier C
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):935-43. PubMed ID: 11787358
[TBL] [Abstract][Full Text] [Related]
18. Atypical inflammatory demyelinating syndromes of the CNS.
Hardy TA; Reddel SW; Barnett MH; Palace J; Lucchinetti CF; Weinshenker BG
Lancet Neurol; 2016 Aug; 15(9):967-981. PubMed ID: 27478954
[TBL] [Abstract][Full Text] [Related]
19. Lessons from the neuropathology of atypical forms of multiple sclerosis.
Stadelmann C; Brück W
Neurol Sci; 2004 Nov; 25 Suppl 4():S319-22. PubMed ID: 15727225
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the spectrum of demyelinating disease in Western Australia.
Wu JS; Zhang MN; Carroll WM; Kermode AG
J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1022-6. PubMed ID: 18356258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
